te Boekhorst Paul Francis Olivier
President and CEO
te Boekhorst Paul Francis Olivier has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 22, 2026.
On the most recent filing, te Boekhorst Paul Francis Olivier is listed as President and CEO at IMMUCELL CORP. Inside the rolling window, te Boekhorst Paul Francis Olivier reported 4 open-market purchases totaling $156K in ICCC and no open-market sales. The largest disclosed transaction in the window is a purchase of 8,000 ICCC shares on Jun 18, 2026, worth $76K.
Companies traded
Other insiders at ICCC
Insider Buying
$156K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has te Boekhorst Paul Francis Olivier made?
te Boekhorst Paul Francis Olivier has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does te Boekhorst Paul Francis Olivier trade?
te Boekhorst Paul Francis Olivier has filed SEC Form 4 disclosures for 1 company, including ICCC.
When was te Boekhorst Paul Francis Olivier's most recent SEC Form 4 filing?
te Boekhorst Paul Francis Olivier's most recent SEC Form 4 filing on Tracefour is dated Jun 22, 2026.
What is te Boekhorst Paul Francis Olivier's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, te Boekhorst Paul Francis Olivier is listed as President and CEO.
What is te Boekhorst Paul Francis Olivier's total buy and sell value in the current window?
Inside the rolling retention window, te Boekhorst Paul Francis Olivier bought $156K and sold $0 based on SEC Form 4 filings.
What was te Boekhorst Paul Francis Olivier's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 8,000 ICCC shares on 2026-06-18, worth $76K, per SEC Form 4 filings.